The legacy of the blue pill offers a intricate case study for stakeholders eyeing pharma. While early sales were astounding, present patent lapse and the arrival of generic versions have considerably impacted earnings. https://janiceuujh591345.isblog.net/the-blue-pill-and-pharma-a-precarious-stake-58322759